Peng Chu Selected Research

Peng Chu Research Topics

Disease

10	Neoplasms (Cancer) 12/2023 - 12/2017
6	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 01/2018
6	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2015
4	Inflammation (Inflammations) 08/2023 - 11/2016
4	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 01/2018
3	Atrial Fibrillation 07/2020 - 12/2019
3	Atherosclerosis 01/2017 - 12/2015
2	Fatigue 01/2020 - 12/2019
2	Lung Neoplasms (Lung Cancer) 12/2017 - 11/2016
1	Neoplasm Metastasis (Metastasis) 12/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023
1	Hypoxia (Hypoxemia) 11/2022
1	Cardiotoxicity 09/2022
1	Cardiomyopathies (Cardiomyopathy) 09/2022
1	Hepatocellular Carcinoma (Hepatoma) 11/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Pulmonary Hypertension 07/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Colitis 01/2020
1	Coronary Disease (Coronary Heart Disease) 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Heart Failure 12/2019
1	Respiratory Sounds (Crackle) 12/2019
1	Disease Resistance 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Infections 01/2019
1	Insulin Resistance 11/2018
1	Hyperpigmentation 08/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017

Drug/Important Bio-Agent (IBA)

7	Oleanolic AcidIBA 11/2022 - 12/2015
4	Phosphocreatine (Neoton)IBA 02/2022 - 12/2015
3	K73-03IBA 11/2022 - 11/2020
3	2- morpholinomethyl- 3- oxoolean- 12- en- 28- oic acidIBA 01/2018 - 01/2016
2	Ubiquitin-Specific ProteasesIBA 12/2023 - 11/2022
2	Neuroprotective AgentsIBA 02/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 11/2021 - 10/2020
2	Kazal Pancreatic Trypsin InhibitorIBA 10/2021 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 11/2018
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 12/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 12/2015
2	SZC017IBA 12/2017 - 12/2015
1	rottlerinIBA 12/2023
1	morusinIBA 12/2023
1	NucleophosminIBA 10/2023
1	CopperIBA 08/2023
1	SolutionsIBA 01/2023
1	Dopamine (Intropin)FDA LinkGeneric 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2022
1	Deubiquitinating EnzymesIBA 11/2022
1	IronIBA 09/2022
1	Sirtuin 3IBA 09/2022
1	Sirtuin 1IBA 09/2022
1	CalciumIBA 09/2022
1	SirtuinsIBA 09/2022
1	jugloneIBA 04/2022
1	Long Noncoding RNAIBA 11/2021
1	Gemcitabine FDA Link 10/2021
1	indium-bleomycinIBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	SeleniumIBA 01/2021
1	Exportin 1 ProteinIBA 01/2021
1	Aurora Kinase AIBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	CateninsIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Ribonuclease III (RNase III)IBA 01/2021
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2021
1	CollagenIBA 01/2021
1	N-methyladenosineIBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 07/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Aldehyde DehydrogenaseIBA 01/2020
1	(R,S)- 4- ((4'- methoxy- 4- (methyl)- 3- ((4- methoxyphenyl)ethynyl)biphenyl- 2- yl)(4- methoxyphenyl)methylene)- 2,5- cyclohexadien- 1- one,IBA 01/2020
1	CathelicidinsIBA 01/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	Lactate Dehydrogenase 5IBA 01/2019
1	CytokinesIBA 01/2019
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019
1	Endoplasmic Reticulum Chaperone BiPIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	CosmeticsIBA 08/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	HomocysteineIBA 01/2017
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2017
1	AntioxidantsIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2017
1	Betulinic AcidIBA 12/2016
1	Estrogen ReceptorsIBA 12/2016
1	TriterpenesIBA 12/2016
1	CyclinsIBA 12/2016

Therapy/Procedure

4	Therapeutics 01/2023 - 12/2016
1	Pancreaticoduodenectomy 01/2022
1	Immunotherapy 10/2020
1	Oral Administration 01/2020
1	Intraperitoneal Injections 01/2019
1	Drug Therapy (Chemotherapy) 01/2018